|
It has recently been discovered that certain cancers result from a small number of seed cells that give rise to the large number of tumor cells. These seed cells appear to have the ability both to create large numbers of cancer tumor cells and to duplicate themselves. In this sense, they are very much like stem cells, and have come to be referred to as cancer stem cells. If cancer stem cells are resistant to conventional therapies, they may be a cause of many cancer treatment failures.
Targeting these cancer stem cells with cell-specific inhibitors may lead to new therapies for intractable cancers, but these cells must first be isolated. Cellerant is using its knowledge of the blood forming system and our ability to obtain these unique targets and develop antibody-based therapies against them.
|